TREATMENT OF POSTMENOPAUSAL COMPLAINTS IN BREAST CANCER PATIENTS COMPRISING TIBOLONE AND A SERM

Details for Australian Patent Application No. 2003273170 (hide)

Owner AKZO NOBEL N.V.

Inventors Kloosterboer, Helenius Jan; Adang, Anton Egbert Peter

Agent Spruson & Ferguson

Pub. Number AU-A-2003273170

PCT Number PCT/EP03/50178

PCT Pub. Number WO2003/099292

Priority 02077050.9 24.05.02 EP

Filing date 20 May 2003

Wipo publication date 12 December 2003

International Classifications

A61K 031/567 - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 031/4535

A61K 031/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 031/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

Event Publications

29 January 2004 Complete Application Filed

  Priority application(s): 02077050.9 24.05.02 EP

5 February 2004 Application Open to Public Inspection

  Published as AU-A-2003273170

2 November 2006 Assignment before Grant

  Akzo Nobel N.V. The application has been assigned to N.V. Organon

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003273171-IMMUNOMODULATORY COMPOUNDS AND METHODS OF USE THEREOF

2003273169-7-PHENYLSULFONYL-TETRAHYDRO -3-BENZAZEPINE DERIVATIVES AS ANTIPSYCHOTIC AGENTS